These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M. Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772 [Abstract] [Full Text] [Related]
8. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience. Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M. In Vivo; 2009 Mar; 23(4):639-44. PubMed ID: 19567401 [Abstract] [Full Text] [Related]
9. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972 [Abstract] [Full Text] [Related]
10. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dayal S, Taflampas P, Riss S, Chandrakumaran K, Cecil TD, Mohamed F, Moran BJ. Dis Colon Rectum; 2013 Dec; 56(12):1366-72. PubMed ID: 24201390 [Abstract] [Full Text] [Related]
12. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Sugarbaker PH. Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099 [Abstract] [Full Text] [Related]
13. Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications. Smeenk RM, Bex A, Verwaal VJ, Horenblas S, Zoetmulder FA. J Surg Oncol; 2006 Jan 01; 93(1):20-3. PubMed ID: 16353186 [Abstract] [Full Text] [Related]
14. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center. Deraco M, Kusamura S, Laterza B, Favaro M, Fumagalli L, Costanzo P, Baratti D. In Vivo; 2006 Jan 01; 20(6A):773-6. PubMed ID: 17203766 [Abstract] [Full Text] [Related]
16. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei. Hsu KH, Chou CY, Chang YC. Hepatogastroenterology; 2007 Jan 01; 54(73):47-52. PubMed ID: 17419229 [Abstract] [Full Text] [Related]
17. Pseudomyxoma peritonei: a review of 23 cases. Wertheim I, Fleischhacker D, McLachlin CM, Rice LW, Berkowitz RS, Goff BA. Obstet Gynecol; 1994 Jul 01; 84(1):17-21. PubMed ID: 8008316 [Abstract] [Full Text] [Related]
18. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy]. Smeenk RM, Verwaal VJ, Zoetmulder FA. Ned Tijdschr Geneeskd; 2007 Feb 17; 151(7):418-23. PubMed ID: 17343142 [Abstract] [Full Text] [Related]
19. Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei. Chua TC, Yan TD, Yap ZL, Horton MD, Fermanis GG, Morris DL. J Surg Oncol; 2009 Apr 01; 99(5):292-5. PubMed ID: 19180588 [Abstract] [Full Text] [Related]